Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $766,055 - $894,581
4,949 New
4,949 $848,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $1.35 Million - $1.62 Million
-9,773 Reduced 11.7%
73,762 $11.9 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $2.4 Million - $2.76 Million
-17,911 Reduced 17.66%
83,535 $11.2 Million
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $3.17 Million - $4.03 Million
-23,058 Reduced 18.52%
101,446 $15.5 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $1.56 Million - $1.93 Million
-11,815 Reduced 8.67%
124,504 $20.2 Million
Q4 2021

Jan 25, 2022

BUY
$107.43 - $135.93 $223,669 - $283,006
2,082 Added 1.55%
136,319 $18.5 Million
Q3 2021

Dec 01, 2021

SELL
$106.4 - $120.78 $462,520 - $525,030
-4,347 Reduced 3.14%
134,237 $14.5 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $55,235 - $61,535
525 Added 0.38%
138,584 $15.6 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $414,110 - $455,885
4,048 Added 3.02%
138,059 $14.9 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $2.03 Million - $2.74 Million
25,174 Added 23.13%
134,011 $14.4 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $251,888 - $295,633
2,932 Added 2.77%
108,837 $9.53 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $5.17 Million - $6.91 Million
70,420 Added 198.45%
105,905 $10.4 Million
Q1 2020

Jun 09, 2020

SELL
$64.5 - $97.79 $58,050 - $88,011
-900 Reduced 2.47%
35,485 $2.7 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $2.62 Million - $3.28 Million
36,385 New
36,385 $3.22 Million
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $285,138 - $364,473
-4,340 Closed
0 $0
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $2.32 Million - $2.73 Million
-30,035 Reduced 87.37%
4,340 $350,000
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $6.17 Million - $7.61 Million
-79,301 Reduced 69.76%
34,375 $3.17 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $1.44 Million - $1.6 Million
-16,196 Reduced 12.47%
113,676 $10.8 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $335,058 - $396,450
3,732 Added 2.96%
129,872 $12 Million
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $68,363 - $91,545
-743 Reduced 0.59%
126,140 $11.9 Million
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $7.6 Million - $8.34 Million
84,908 Added 202.28%
126,883 $12.3 Million
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $2.93 Million - $3.75 Million
41,975
41,975 $3.73 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.